On 5 June the Therapeutic Goods Administration (TGA) released a safety update following reports of the live-attenuated influenza vaccine FluMist being administered to children to children under 2 years of age.
FluMist is not indicated for young children under 24 months of age. Health professionals are advised to confirm the child’s age before administration, and review FluMist product information.
Read the safety update in full at TGA: Be alert to FluMist indicated age range
For more information about influenza disease and vaccination, visit MVEC: Influenza